506 related articles for article (PubMed ID: 28989014)
1. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
Newman A; Reutzel-Edens SM; Zografi G
J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
[TBL] [Abstract][Full Text] [Related]
2. An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties.
Newman A; Zografi G
J Pharm Sci; 2019 Mar; 108(3):1061-1080. PubMed ID: 30391302
[TBL] [Abstract][Full Text] [Related]
3. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
Stocker MW; Healy AM; Ferguson S
Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
[TBL] [Abstract][Full Text] [Related]
4. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
5. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
[TBL] [Abstract][Full Text] [Related]
6. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
Qian F; Huang J; Hussain MA
J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
[TBL] [Abstract][Full Text] [Related]
7. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical cocrystals: walking the talk.
Bolla G; Nangia A
Chem Commun (Camb); 2016 Jun; 52(54):8342-60. PubMed ID: 27278109
[TBL] [Abstract][Full Text] [Related]
9. Emerging trends in the stabilization of amorphous drugs.
Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
[TBL] [Abstract][Full Text] [Related]
10. Manufacturing Amorphous Solid Dispersions with a Tailored Amount of Crystallized API for Biopharmaceutical Testing.
Theil F; Milsmann J; Anantharaman S; van Lishaut H
Mol Pharm; 2018 May; 15(5):1870-1877. PubMed ID: 29648833
[TBL] [Abstract][Full Text] [Related]
11. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
12. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
13. Application of Vibrational Spectroscopy to Study Solid-state Transformations of Pharmaceuticals.
Erxleben A
Curr Pharm Des; 2016; 22(32):4883-4911. PubMed ID: 27464723
[TBL] [Abstract][Full Text] [Related]
14. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
Baghel S; Cathcart H; O'Reilly NJ
J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
[TBL] [Abstract][Full Text] [Related]
15. Coamorphous repaglinide-saccharin with enhanced dissolution.
Gao Y; Liao J; Qi X; Zhang J
Int J Pharm; 2013 Jun; 450(1-2):290-5. PubMed ID: 23612357
[TBL] [Abstract][Full Text] [Related]
16. Influence of the p
Hu Y; Guo Y; Li B; Xu R; Fang X; Cao Y; Liu Z; Jiang C; Lu S
ACS Omega; 2021 Feb; 6(4):3106-3119. PubMed ID: 33553927
[TBL] [Abstract][Full Text] [Related]
17. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
[TBL] [Abstract][Full Text] [Related]
18. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection.
Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610
[TBL] [Abstract][Full Text] [Related]
19. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
Manchanda D; Kumar A; Nanda A
Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
[TBL] [Abstract][Full Text] [Related]
20. Crystallization kinetics and molecular dynamics of binary coamorphous systems of nimesulide and profen analogs.
Zhang J; Shi Q; Qu T; Zhou D; Cai T
Int J Pharm; 2021 Dec; 610():121235. PubMed ID: 34743960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]